{"gene":"NOL9","run_date":"2026-04-29T11:37:57","timeline":{"discoveries":[{"year":2010,"finding":"NOL9 (human) is a nucleolar polynucleotide 5'-kinase that sediments with pre-60S ribosomal particles in HeLa nuclear extracts. Knockdown of NOL9 severely impairs ribosome biogenesis; specifically, the kinase activity of NOL9 is required for efficient generation of 5.8S and 28S rRNAs from the 32S precursor, and depletion causes a maturation defect at the 5' end of the predominant 5.8S short-form rRNA (5.8S-S), likely by impairing 5'→3' exonucleolytic trimming.","method":"siRNA knockdown in HeLa cells, sucrose gradient sedimentation/fractionation, in vitro polynucleotide kinase assay, Northern blotting for rRNA intermediates","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1–2 — enzymatic activity demonstrated in vitro, loss-of-function with specific rRNA processing phenotype, multiple orthogonal methods in single study","pmids":["21063389"],"is_preprint":false},{"year":2010,"finding":"Grc3 (the yeast ortholog of NOL9) encodes a polynucleotide kinase required for efficient transcription termination by RNA polymerase I in S. cerevisiae, acting by controlling the phosphorylation status of the downstream Rnt1 cleavage product to regulate its accessibility to the torpedo exonuclease Rat1.","method":"Genetic depletion of GRC3, in vitro polynucleotide kinase assay, ChIP and transcription run-on assays for Pol I termination","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 1–2 — enzymatic activity demonstrated in vitro, genetic loss-of-function with defined molecular mechanism for Pol I termination","pmids":["20814424"],"is_preprint":false},{"year":2012,"finding":"In S. cerevisiae, Las1 (ortholog of human Las1L, NOL9's binding partner) co-precipitates primarily with 27S rRNA and associates with an Nsa1/Rix1-containing pre-60S particle. Grc3 (NOL9 ortholog) is identified as a major Las1-interacting protein; Grc3 kinase activity is required for efficient pre-rRNA processing, and Grc3 depletion causes rRNA processing defects similar to Las1 depletion, indicating they function together.","method":"Co-immunoprecipitation, sucrose gradient sedimentation, genetic depletion, Northern blotting","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP, epistatic genetic analysis, multiple orthogonal methods confirming Las1–Grc3 functional cooperation","pmids":["23175604"],"is_preprint":false},{"year":2011,"finding":"In fission yeast S. pombe, Grc3 (NOL9 ortholog) is required for both 25S rRNA processing and heterochromatic gene silencing. Protein complex analysis identified Las1 and components of the IPI complex (Rix1, Ipi1, Crb3) as Grc3-interacting proteins, and Grc3 localizes dynamically between heterochromatic regions and the perinucleolar region in a manner dependent on Swi6/Clr4.","method":"Affinity purification/mass spectrometry, genetic depletion, cytological localization, Northern blotting, silencing reporter assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2–3 — AP-MS interactome, genetic loss-of-function with dual phenotypic readouts; single lab","pmids":["21385875"],"is_preprint":false},{"year":2017,"finding":"The Las1L endoribonuclease (human) requires its binding partner Grc3 (NOL9 ortholog in yeast) for specific C2 cleavage of pre-rRNA both in vitro and in vivo. Grc3 and Las1 assemble into a tetrameric complex; Las1 reciprocally activates Grc3 kinase activity exclusively toward single-stranded RNA substrates. This cross-activation establishes Grc3/Las1 as a unique member of the RNaseL/Ire1 RNA splicing family.","method":"In vitro reconstitution of endoribonuclease cleavage assay, in vitro polynucleotide kinase assay, site-directed mutagenesis, in vivo pre-rRNA processing assays in S. cerevisiae, native mass spectrometry for complex stoichiometry","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with mutagenesis, validated in vivo, multiple orthogonal methods; strong mechanistic resolution","pmids":["28652339"],"is_preprint":false},{"year":2018,"finding":"Grc3 (NOL9 ortholog) has distinct substrate preference for RNA over DNA substrates in vitro. Disruption of conserved residues at the Grc3 kinase active site abolishes Grc3-directed Las1-mediated pre-rRNA cleavage both in vitro and in vivo, establishing that Grc3 kinase activity is directly coupled to Las1 endonuclease activity during pre-rRNA processing.","method":"In vitro polynucleotide kinase assay with RNA/DNA substrates, active-site mutagenesis, in vitro cleavage assay, in vivo pre-rRNA processing assays in S. cerevisiae","journal":"RNA (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 1 — enzymatic reconstitution with active-site mutagenesis validated in vivo","pmids":["29440475"],"is_preprint":false},{"year":2019,"finding":"Human NOL9 forms a higher-order complex with Las1L to constitute the ITS2 pre-rRNA endonuclease-kinase machinery. NOL9 contains a nucleolar localization sequence (NoLS) that is responsible for nucleolar transport of the assembled Las1L–NOL9 complex. Structural analysis by high-resolution imaging defines the spatial organization of Las1L–NOL9 within nucleolar sub-structures linked to late pre-rRNA processing. Specific regions of both proteins orchestrate the intricate higher-order architecture of the complex.","method":"Co-immunoprecipitation, deletion mapping, confocal and super-resolution fluorescence microscopy (nucleolar sub-structure imaging), subcellular fractionation, domain mutagenesis","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP with deletion analysis, direct localization with functional NoLS mapping, multiple orthogonal methods","pmids":["31288032"],"is_preprint":false},{"year":2015,"finding":"In zebrafish, loss-of-function mutation of nol9 causes defective 28S rRNA processing, hypoplastic pancreas, liver, and intestine, and reduced hematopoietic stem/progenitor cells, definitive erythrocytes, and lymphocytes due to impaired proliferation of progenitor cells. The hematopoietic (but not pancreatic) defects are rescued by genetic loss of Tp53, indicating that the hematopoietic phenotype is p53-dependent. mTOR pathway activation by L-Leucine does not rescue either defect.","method":"Forward genetic screen, loss-of-function zebrafish mutant, Northern blotting for rRNA, genetic epistasis with tp53 mutant, L-Leucine mTOR activation, flow cytometry, ultrastructural analysis","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 2 — clean loss-of-function in vertebrate model with defined molecular (rRNA processing) and cellular phenotypes, genetic epistasis establishing p53-dependent pathway","pmids":["26624285"],"is_preprint":false},{"year":2023,"finding":"The LAS1–NOL9 protein–protein interaction is required for 28S rRNA maturation; covalent inhibition of LAS1 at C264 by the compound HEN-463 disrupts LAS1–NOL9 interaction, causes cytoplasmic translocation of LAS1, inhibits 28S rRNA maturation, activates the NPM1–MDM2–p53 pathway leading to p53 stabilization, and selectively kills NPM1-mutant AML cells.","method":"Covalent small-molecule targeting, co-immunoprecipitation (LAS1–NOL9 interaction), subcellular fractionation/immunofluorescence (LAS1 translocation), Northern/qRT-PCR (rRNA processing), Western blotting (p53 pathway), cell viability and apoptosis assays","journal":"Pharmacological research","confidence":"Medium","confidence_rationale":"Tier 2–3 — Co-IP disruption with functional rRNA and pathway readouts; single lab, pharmacological rather than genetic dissection of NOL9 function per se","pmids":["36796466"],"is_preprint":false},{"year":2025,"finding":"NOL9 expression in hepatocellular carcinoma (HCC) is regulated by DNA methylation at specific CpG sites (involving DNMT1) and by the transcription factor ZNF384. NOL9 knockdown inhibits HCC cell proliferation and promotes apoptosis in vitro and reduces tumor growth in vivo; overexpression has the opposite effect. Mechanistically, NOL9-mediated cell proliferation in HCC is dependent on activation of the Wnt/β-catenin signaling pathway.","method":"siRNA knockdown and overexpression in HCC cell lines, in vivo xenograft tumor growth assay, bisulfite sequencing/methylation analysis, luciferase reporter and Western blotting for Wnt/β-catenin pathway, flow cytometry (apoptosis/cell cycle)","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2–3 — loss- and gain-of-function with in vivo validation and pathway reporter; single lab, Wnt/β-catenin link is mechanistic but upstream connection to NOL9's known kinase activity is not established","pmids":["39955289"],"is_preprint":false}],"current_model":"NOL9 is a nucleolar polynucleotide 5'-kinase that associates with pre-60S ribosomal particles and, together with the endoribonuclease Las1L, forms a higher-order tetrameric ITS2 endonuclease-kinase complex in which NOL9's kinase activity phosphorylates pre-rRNA cleavage products and Las1L reciprocally activates NOL9 kinase activity toward single-stranded RNA; this coupled cleavage-phosphorylation is required for processing of the 32S precursor into mature 5.8S and 28S rRNAs, and NOL9 encodes a nucleolar localization sequence that directs the assembled Las1L–NOL9 complex to the nucleolus for late pre-rRNA processing events."},"narrative":{"teleology":[{"year":2010,"claim":"Establishing NOL9/Grc3 as an RNA 5'-kinase linked to ribosome biogenesis resolved the enzymatic identity of the gene and showed its kinase activity is required for 32S pre-rRNA processing to generate 5.8S and 28S rRNAs.","evidence":"siRNA knockdown in HeLa cells, in vitro polynucleotide kinase assay, sucrose gradient sedimentation, Northern blotting (human); genetic depletion, ChIP, Pol I transcription run-on (yeast)","pmids":["21063389","20814424"],"confidence":"High","gaps":["Identity of the direct RNA substrates phosphorylated by NOL9 in vivo was not determined","How NOL9 kinase activity feeds into exonucleolytic trimming remained unclear","Whether NOL9 acts alone or requires a partner was unknown"]},{"year":2012,"claim":"Identification of Las1 as the major Grc3/NOL9-interacting protein demonstrated that the kinase functions within a dedicated endonuclease–kinase module on pre-60S particles, explaining the epistatic overlap of their depletion phenotypes.","evidence":"Reciprocal co-immunoprecipitation, genetic depletion, AP-MS, Northern blotting in S. cerevisiae and S. pombe","pmids":["23175604","21385875"],"confidence":"High","gaps":["Stoichiometry and architecture of the Las1–Grc3 complex were unresolved","Whether Las1 endonuclease activity depends on Grc3 was not tested biochemically","The Grc3 role in heterochromatic silencing reported in S. pombe was not confirmed in other organisms"]},{"year":2015,"claim":"A vertebrate loss-of-function model in zebrafish established that nol9 is essential for organismal development, linking defective 28S rRNA processing to p53-dependent hematopoietic failure and p53-independent visceral organ hypoplasia.","evidence":"Forward genetic screen, nol9 mutant zebrafish, Northern blot for rRNA, genetic epistasis with tp53","pmids":["26624285"],"confidence":"High","gaps":["Whether the p53-independent pancreatic phenotype reflects a ribosome-independent NOL9 function was unclear","Mammalian in vivo consequences of NOL9 loss were not examined"]},{"year":2017,"claim":"Biochemical reconstitution revealed that Las1 and Grc3 cross-activate each other — Las1 stimulates Grc3 kinase activity toward ssRNA and Grc3 is required for Las1 C2 endonuclease cleavage — establishing a coupled cleavage-phosphorylation mechanism for ITS2 processing.","evidence":"In vitro reconstitution of endonuclease and kinase assays, active-site mutagenesis validated in vivo, native mass spectrometry for tetrameric stoichiometry in S. cerevisiae","pmids":["28652339","29440475"],"confidence":"High","gaps":["Structural basis for reciprocal activation was not determined","Whether the human Las1L–NOL9 complex has identical stoichiometry and cross-activation was not directly shown"]},{"year":2019,"claim":"Mapping the human Las1L–NOL9 complex architecture showed that NOL9 carries a nucleolar localization sequence responsible for directing the assembled complex to the nucleolus, explaining how the ITS2 processing machinery reaches its substrate.","evidence":"Deletion mapping, co-immunoprecipitation, confocal and super-resolution microscopy of nucleolar sub-structures in human cells","pmids":["31288032"],"confidence":"High","gaps":["High-resolution atomic structure of the human Las1L–NOL9 complex is still lacking","Whether additional factors regulate nucleolar import or retention of the complex is unknown"]},{"year":2023,"claim":"Pharmacological disruption of the LAS1–NOL9 interaction by a covalent LAS1 inhibitor confirmed the interaction is functionally essential for 28S rRNA maturation and demonstrated that its loss activates the NPM1–MDM2–p53 nucleolar stress pathway, with therapeutic selectivity in NPM1-mutant AML.","evidence":"Covalent small-molecule targeting of LAS1 C264, co-immunoprecipitation, Northern blot, subcellular fractionation, cell viability assays in AML lines","pmids":["36796466"],"confidence":"Medium","gaps":["Pharmacological specificity of HEN-463 beyond LAS1 was not exhaustively profiled","Whether NOL9 protein stability or activity is directly affected by the compound is unclear","In vivo efficacy in AML models was not reported"]},{"year":2025,"claim":"NOL9 was linked to hepatocellular carcinoma cell proliferation via Wnt/β-catenin signaling, expanding its functional repertoire beyond ribosome biogenesis, though the mechanistic bridge between NOL9's kinase activity and Wnt pathway activation is undefined.","evidence":"siRNA knockdown and overexpression in HCC cell lines, in vivo xenograft, bisulfite sequencing, luciferase reporter for Wnt pathway","pmids":["39955289"],"confidence":"Medium","gaps":["No mechanistic connection between NOL9 polynucleotide kinase activity and Wnt/β-catenin signaling was established","Whether the proliferative effect is secondary to ribosome biogenesis defects and p53 activation was not tested","Single-lab finding without independent replication"]},{"year":null,"claim":"An atomic-resolution structure of the human Las1L–NOL9 complex and identification of the in vivo RNA substrates phosphorylated by NOL9 remain key open questions for understanding how coupled cleavage-phosphorylation is orchestrated during ITS2 processing.","evidence":"","pmids":[],"confidence":"High","gaps":["No high-resolution structure of the human Las1L–NOL9 complex exists","The precise in vivo RNA substrates of NOL9 kinase have not been mapped by crosslinking or related approaches","Whether NOL9 has physiologically relevant functions outside ribosome biogenesis remains unresolved"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0,1,4,5]},{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[0,4,5]}],"localization":[{"term_id":"GO:0005730","term_label":"nucleolus","supporting_discovery_ids":[0,6]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[3,6]}],"pathway":[{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[0,4,5,7]},{"term_id":"R-HSA-1852241","term_label":"Organelle biogenesis and maintenance","supporting_discovery_ids":[0,7]}],"complexes":["Las1L–NOL9 ITS2 endonuclease-kinase complex","pre-60S ribosomal particle"],"partners":["LAS1L","RIX1","IPI1","NSA1"],"other_free_text":[]},"mechanistic_narrative":"NOL9 is a nucleolar polynucleotide 5'-hydroxyl-kinase essential for ribosome biogenesis, specifically the processing of the 32S precursor into mature 5.8S and 28S rRNAs. NOL9 forms a tetrameric complex with the endoribonuclease Las1L in which Las1L reciprocally activates NOL9 kinase activity toward single-stranded RNA, coupling ITS2 endonucleolytic cleavage to 5'-phosphorylation of cleavage products required for subsequent exonucleolytic trimming [PMID:28652339, PMID:29440475]. NOL9 encodes a nucleolar localization sequence that directs the assembled Las1L–NOL9 complex to the nucleolus for late pre-rRNA processing [PMID:31288032]. Loss of NOL9 function in zebrafish causes defective 28S rRNA processing, p53-dependent hematopoietic failure, and visceral organ hypoplasia, and disruption of the LAS1–NOL9 interaction pharmacologically activates the NPM1–MDM2–p53 surveillance pathway [PMID:26624285, PMID:36796466]."},"prefetch_data":{"uniprot":{"accession":"Q5SY16","full_name":"Polynucleotide 5'-hydroxyl-kinase NOL9","aliases":["Nucleolar protein 9"],"length_aa":702,"mass_kda":79.3,"function":"Polynucleotide kinase that can phosphorylate the 5'-hydroxyl groups of single-stranded and double-stranded RNA and DNA substrates (PubMed:21063389). Involved in rRNA processing and its kinase activity is required for the processing of the 32S precursor into 5.8S and 28S rRNAs, more specifically for the generation of the major 5.8S(S) form (PubMed:21063389). Required for the efficient pre-rRNA processing of internal transcribed spacer 2 (ITS2) (PubMed:21063389). Associates with LAS1L to form an ITS2 pre-rRNA endonuclease-kinase complex and is responsible for the transport of this complex into the nucleolus (PubMed:31288032)","subcellular_location":"Nucleus; Nucleus, nucleolus","url":"https://www.uniprot.org/uniprotkb/Q5SY16/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/NOL9","classification":"Common Essential","n_dependent_lines":1168,"n_total_lines":1208,"dependency_fraction":0.9668874172185431},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"IPO5","stoichiometry":0.2},{"gene":"NPM1","stoichiometry":0.2},{"gene":"PSPC1","stoichiometry":0.2},{"gene":"SRP9","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/NOL9","total_profiled":1310},"omim":[{"mim_id":"620304","title":"NUCLEOLAR PROTEIN 9; NOL9","url":"https://www.omim.org/entry/620304"},{"mim_id":"609455","title":"PROLINE-, GLUTAMIC ACID-, AND LEUCINE-RICH PROTEIN 1; PELP1","url":"https://www.omim.org/entry/609455"},{"mim_id":"608757","title":"CLEAVAGE FACTOR POLYNUCLEOTIDE KINASE SUBUNIT 1; CLP1","url":"https://www.omim.org/entry/608757"},{"mim_id":"300964","title":"LAS1-LIKE RIBOSOME BIOGENESIS FACTOR; LAS1L","url":"https://www.omim.org/entry/300964"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoli","reliability":"Supported"},{"location":"Intermediate filaments","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/NOL9"},"hgnc":{"alias_symbol":["FLJ23323","NET6","Grc3"],"prev_symbol":[]},"alphafold":{"accession":"Q5SY16","domains":[{"cath_id":"2.60.120.1030","chopping":"117-274","consensus_level":"high","plddt":89.1404,"start":117,"end":274},{"cath_id":"3.40.50.300","chopping":"280-464_491-501","consensus_level":"high","plddt":92.8431,"start":280,"end":501},{"cath_id":"2.40.30.330","chopping":"544-653","consensus_level":"high","plddt":92.4416,"start":544,"end":653}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q5SY16","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q5SY16-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q5SY16-F1-predicted_aligned_error_v6.png","plddt_mean":77.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NOL9","jax_strain_url":"https://www.jax.org/strain/search?query=NOL9"},"sequence":{"accession":"Q5SY16","fasta_url":"https://rest.uniprot.org/uniprotkb/Q5SY16.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q5SY16/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q5SY16"}},"corpus_meta":[{"pmid":"23175604","id":"PMC_23175604","title":"Las1 interacts with Grc3 polynucleotide kinase and is required for ribosome synthesis in Saccharomyces cerevisiae.","date":"2012","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/23175604","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17965585","id":"PMC_17965585","title":"Expression and function of transmembrane-4 superfamily (tetraspanin) proteins in osteoclasts: reciprocal roles of Tspan-5 and NET-6 during osteoclastogenesis.","date":"2007","source":"Allergology international : official journal of the Japanese Society of Allergology","url":"https://pubmed.ncbi.nlm.nih.gov/17965585","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28652339","id":"PMC_28652339","title":"Grc3 programs the essential endoribonuclease Las1 for specific RNA cleavage.","date":"2017","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/28652339","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21063389","id":"PMC_21063389","title":"Nol9 is a novel polynucleotide 5'-kinase involved in ribosomal RNA processing.","date":"2010","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/21063389","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20814424","id":"PMC_20814424","title":"Role of the RNA/DNA kinase Grc3 in transcription termination by RNA polymerase I.","date":"2010","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/20814424","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17486367","id":"PMC_17486367","title":"The tetraspanin superfamily member NET-6 is a new tumor suppressor gene.","date":"2007","source":"Journal of cancer research and clinical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/17486367","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26624285","id":"PMC_26624285","title":"The Ribosome Biogenesis Protein Nol9 Is Essential for Definitive Hematopoiesis and Pancreas Morphogenesis in Zebrafish.","date":"2015","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26624285","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21385875","id":"PMC_21385875","title":"Roles of fission yeast Grc3 protein in ribosomal RNA processing and heterochromatic gene silencing.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21385875","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31004251","id":"PMC_31004251","title":"Expression of tetraspanins NET-6 and CD151 in breast cancer as a potential tumor biomarker.","date":"2019","source":"Clinical and experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31004251","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31288032","id":"PMC_31288032","title":"Nol9 Is a Spatial Regulator for the Human ITS2 Pre-rRNA Endonuclease-Kinase Complex.","date":"2019","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/31288032","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29440475","id":"PMC_29440475","title":"Characterization of the molecular crosstalk within the essential Grc3/Las1 pre-rRNA processing complex.","date":"2018","source":"RNA (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/29440475","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39955289","id":"PMC_39955289","title":"Nucleolar NOL9 regulated by DNA methylation promotes hepatocellular carcinoma growth through activation of Wnt/β-catenin signaling pathway.","date":"2025","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/39955289","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36796466","id":"PMC_36796466","title":"Covalent targeting the LAS1-NOL9 axis for selective treatment in NPM1 mutant acute myeloid leukemia.","date":"2023","source":"Pharmacological research","url":"https://pubmed.ncbi.nlm.nih.gov/36796466","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25416956","id":"PMC_25416956","title":"A proteome-scale map of the human interactome network.","date":"2014","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25416956","citation_count":977,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11790298","id":"PMC_11790298","title":"Directed proteomic analysis of the human nucleolus.","date":"2002","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/11790298","citation_count":780,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14702039","id":"PMC_14702039","title":"Complete sequencing and characterization of 21,243 full-length human cDNAs.","date":"2003","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14702039","citation_count":754,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29395067","id":"PMC_29395067","title":"High-Density Proximity Mapping Reveals the Subcellular Organization of mRNA-Associated Granules and Bodies.","date":"2018","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/29395067","citation_count":580,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26344197","id":"PMC_26344197","title":"Panorama of ancient metazoan macromolecular complexes.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26344197","citation_count":407,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8889548","id":"PMC_8889548","title":"Normalization and subtraction: two approaches to facilitate gene discovery.","date":"1996","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/8889548","citation_count":401,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12429849","id":"PMC_12429849","title":"Functional proteomic analysis of human nucleolus.","date":"2002","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/12429849","citation_count":391,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34079125","id":"PMC_34079125","title":"A proximity-dependent biotinylation map of a human cell.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/34079125","citation_count":339,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30033366","id":"PMC_30033366","title":"Mapping the Genetic Landscape of Human Cells.","date":"2018","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/30033366","citation_count":225,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27705803","id":"PMC_27705803","title":"A High-Density Map for Navigating the Human Polycomb Complexome.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/27705803","citation_count":216,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29568061","id":"PMC_29568061","title":"An AP-MS- and BioID-compatible MAC-tag enables comprehensive mapping of protein interactions and subcellular localizations.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29568061","citation_count":201,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26673895","id":"PMC_26673895","title":"A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.","date":"2015","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/26673895","citation_count":198,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25544563","id":"PMC_25544563","title":"Global mapping of herpesvirus-host protein complexes reveals a transcription strategy for late genes.","date":"2014","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/25544563","citation_count":173,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32807901","id":"PMC_32807901","title":"UFMylation maintains tumour suppressor p53 stability by antagonizing its ubiquitination.","date":"2020","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/32807901","citation_count":168,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30804502","id":"PMC_30804502","title":"H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.","date":"2019","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/30804502","citation_count":162,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30415952","id":"PMC_30415952","title":"MYC Protein Interactome Profiling Reveals Functionally Distinct Regions that Cooperate to Drive Tumorigenesis.","date":"2018","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/30415952","citation_count":152,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"31995728","id":"PMC_31995728","title":"AMPK, a Regulator of Metabolism and Autophagy, Is Activated by Lysosomal Damage via a Novel Galectin-Directed Ubiquitin Signal Transduction System.","date":"2020","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/31995728","citation_count":152,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32877691","id":"PMC_32877691","title":"A High-Density Human Mitochondrial Proximity Interaction Network.","date":"2020","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/32877691","citation_count":148,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22586326","id":"PMC_22586326","title":"Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.","date":"2012","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/22586326","citation_count":145,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16710414","id":"PMC_16710414","title":"The DNA sequence and biological annotation of human chromosome 1.","date":"2006","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/16710414","citation_count":144,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19394292","id":"PMC_19394292","title":"Direct binding of CoREST1 to SUMO-2/3 contributes to gene-specific repression by the LSD1/CoREST1/HDAC complex.","date":"2009","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/19394292","citation_count":140,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30554943","id":"PMC_30554943","title":"Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.","date":"2018","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/30554943","citation_count":136,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":7582,"output_tokens":1493,"usd":0.022571},"stage2":{"model":"claude-opus-4-6","input_tokens":4726,"output_tokens":1536,"usd":0.093045},"total_usd":0.405626,"stage1_batch_id":"msgbatch_012ZiiCUBfB62NCTQd4Bk1Jo","stage2_batch_id":"msgbatch_01Xuqq9aUHoQouS7UVGZNStZ","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":19635,"output_tokens":3673,"usd":0.057},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":6693,"output_tokens":4875,"usd":0.23301}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2010,\n      \"finding\": \"Nol9 is a polynucleotide 5'-kinase that sediments primarily with pre-60S ribosomal particles in HeLa nuclear extracts; its kinase activity is required for efficient generation of 5.8S and 28S rRNAs from the 32S precursor, and its depletion causes a specific maturation defect at the 5' end of the predominant 5.8S short-form rRNA, likely by impairing 5'→3' exonucleolytic trimming.\",\n      \"method\": \"Sucrose gradient sedimentation/fractionation of HeLa nuclear extracts, siRNA knockdown with rRNA processing analysis (Northern blotting), in vitro polynucleotide kinase assay\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro kinase assay combined with KD and specific rRNA processing phenotype, single rigorous study with multiple orthogonal methods\",\n      \"pmids\": [\"21063389\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Human Nol9 associates with the Las1L endoribonuclease to form a higher-order ITS2 pre-rRNA endonuclease-kinase complex; Nol9 contains a nucleolar localization sequence responsible for nucleolar transport of the assembled Las1L-Nol9 complex, and structural imaging placed Las1L-Nol9 within the nucleolar sub-structure linked to late pre-rRNA processing events.\",\n      \"method\": \"Co-immunoprecipitation, high-resolution structural imaging (electron microscopy), deletion/domain-mapping analysis, nucleolar localization sequence identification with functional rescue\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — reciprocal Co-IP, structural analysis, and functional localization mapping in a single rigorous study\",\n      \"pmids\": [\"31288032\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Loss-of-function of nol9 in zebrafish causes defects in 28S rRNA processing, impaired proliferation of hematopoietic stem/progenitor cells and pancreatic progenitors; the hematopoietic defect (but not pancreatic defect) is rescued by genetic loss of Tp53, placing Nol9-dependent ribosome biogenesis upstream of a p53-mediated checkpoint.\",\n      \"method\": \"Zebrafish loss-of-function mutant (nol9sa1022), rRNA processing analysis, genetic epistasis with tp53 loss-of-function, mTOR pathway activation with L-Leucine\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean loss-of-function mutant with defined cellular phenotype and genetic epistasis in vertebrate model\",\n      \"pmids\": [\"26624285\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"NOL9 expression in hepatocellular carcinoma cells is regulated by DNA methylation (inversely correlated with CpG methylation, with DNMT1 implicated) and the transcription factor ZNF384; NOL9 knockdown inhibits HCC cell proliferation and promotes apoptosis, effects mediated through suppression of Wnt/β-catenin signaling.\",\n      \"method\": \"siRNA knockdown, overexpression, in vivo tumor xenograft, DNA methylation analysis, Western blotting of Wnt/β-catenin pathway components, ZNF384 transcription factor assay\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — multiple functional assays and pathway readout but mechanistic link between Nol9's kinase activity and Wnt signaling not directly established\",\n      \"pmids\": [\"39955289\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"NOL9 forms a complex with LAS1 that is required for 28S rRNA maturation; covalent inhibition of LAS1 at C264 disrupts the LAS1-NOL9 interaction, causes cytoplasmic translocation of LAS1, and inhibits 28S rRNA processing, stabilizing p53 via the NPM1-MDM2-p53 pathway in NPM1-mutant AML cells.\",\n      \"method\": \"Covalent small-molecule inhibitor (HEN-463) targeting LAS1 C264, co-immunoprecipitation of LAS1-NOL9, rRNA processing analysis, subcellular fractionation/imaging of LAS1 localization, p53 pathway Western blotting\",\n      \"journal\": \"Pharmacological research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — chemical-genetic disruption of LAS1-NOL9 interaction with defined molecular and cellular phenotypes, single study\",\n      \"pmids\": [\"36796466\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NOL9 is a nucleolar polynucleotide 5'-kinase that associates with the Las1L endoribonuclease to form a higher-order ITS2 pre-rRNA endonuclease-kinase complex; Nol9 provides a nucleolar localization sequence that directs nuclear import of the assembled complex, and its kinase activity phosphorylates ITS2 cleavage products to mark them for exonucleolytic degradation, thereby enabling efficient processing of the 32S pre-rRNA into mature 5.8S and 28S rRNAs and 60S ribosomal subunit biogenesis.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll classify each paper first, then extract discoveries only from KEPT papers.\n\n**Classification:**\n\n- [Retrieved 1] Las1/Grc3 in yeast — KEEP (ortholog paper, relevant to NOL9's partner Grc3/Las1L complex)\n- [Retrieved 2] NET-6/Tspan-5 osteoclasts — EXCLUDE (alias collision: NET-6 is TSPAN13, not NOL9)\n- [Retrieved 3] Grc3 programs Las1 endoribonuclease (yeast) — KEEP (ortholog, directly relevant to NOL9's partner)\n- [Retrieved 4] Nol9 polynucleotide 5'-kinase — KEEP (canonical NOL9 paper)\n- [Retrieved 5] Grc3 RNA/DNA kinase Pol I termination (yeast) — KEEP (ortholog, Grc3 is NOL9's yeast ortholog)\n- [Retrieved 6] NET-6 tumor suppressor breast cancer — EXCLUDE (alias collision: NET-6 = TSPAN13)\n- [Retrieved 7] Nol9 zebrafish ribosomopathy — KEEP (canonical NOL9 paper)\n- [Retrieved 8] Fission yeast Grc3 rRNA/heterochromatin — KEEP (ortholog)\n- [Retrieved 9] NET-6/CD151 breast cancer biomarker — EXCLUDE (alias collision)\n- [Retrieved 10] Nol9 spatial regulator ITS2 complex — KEEP (canonical NOL9 paper)\n- [Retrieved 11] Grc3/Las1 crosstalk characterization — KEEP (ortholog, directly mechanistic)\n- [Retrieved 12] NOL9 HCC Wnt/β-catenin — KEEP (canonical NOL9 paper)\n- [Retrieved 13] LAS1-NOL9 axis AML — KEEP (canonical NOL9 paper)\n\n**Curated papers:** Most are large interactome/proteome surveys or unrelated — I'll check for NOL9-specific mechanistic findings. Papers [2],[3],[4],[5],[6] (curated) are cDNA/genome annotation papers. Papers citing BioPlex etc. may list NOL9 as an interactor but contain no mechanistic detail specific to NOL9. I'll skip curated papers that don't add mechanistic specificity beyond what's in the retrieved set.\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2010,\n      \"finding\": \"NOL9 (human) is a nucleolar polynucleotide 5'-kinase that sediments with pre-60S ribosomal particles in HeLa nuclear extracts. Knockdown of NOL9 severely impairs ribosome biogenesis; specifically, the kinase activity of NOL9 is required for efficient generation of 5.8S and 28S rRNAs from the 32S precursor, and depletion causes a maturation defect at the 5' end of the predominant 5.8S short-form rRNA (5.8S-S), likely by impairing 5'→3' exonucleolytic trimming.\",\n      \"method\": \"siRNA knockdown in HeLa cells, sucrose gradient sedimentation/fractionation, in vitro polynucleotide kinase assay, Northern blotting for rRNA intermediates\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — enzymatic activity demonstrated in vitro, loss-of-function with specific rRNA processing phenotype, multiple orthogonal methods in single study\",\n      \"pmids\": [\"21063389\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Grc3 (the yeast ortholog of NOL9) encodes a polynucleotide kinase required for efficient transcription termination by RNA polymerase I in S. cerevisiae, acting by controlling the phosphorylation status of the downstream Rnt1 cleavage product to regulate its accessibility to the torpedo exonuclease Rat1.\",\n      \"method\": \"Genetic depletion of GRC3, in vitro polynucleotide kinase assay, ChIP and transcription run-on assays for Pol I termination\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — enzymatic activity demonstrated in vitro, genetic loss-of-function with defined molecular mechanism for Pol I termination\",\n      \"pmids\": [\"20814424\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"In S. cerevisiae, Las1 (ortholog of human Las1L, NOL9's binding partner) co-precipitates primarily with 27S rRNA and associates with an Nsa1/Rix1-containing pre-60S particle. Grc3 (NOL9 ortholog) is identified as a major Las1-interacting protein; Grc3 kinase activity is required for efficient pre-rRNA processing, and Grc3 depletion causes rRNA processing defects similar to Las1 depletion, indicating they function together.\",\n      \"method\": \"Co-immunoprecipitation, sucrose gradient sedimentation, genetic depletion, Northern blotting\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, epistatic genetic analysis, multiple orthogonal methods confirming Las1–Grc3 functional cooperation\",\n      \"pmids\": [\"23175604\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"In fission yeast S. pombe, Grc3 (NOL9 ortholog) is required for both 25S rRNA processing and heterochromatic gene silencing. Protein complex analysis identified Las1 and components of the IPI complex (Rix1, Ipi1, Crb3) as Grc3-interacting proteins, and Grc3 localizes dynamically between heterochromatic regions and the perinucleolar region in a manner dependent on Swi6/Clr4.\",\n      \"method\": \"Affinity purification/mass spectrometry, genetic depletion, cytological localization, Northern blotting, silencing reporter assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — AP-MS interactome, genetic loss-of-function with dual phenotypic readouts; single lab\",\n      \"pmids\": [\"21385875\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"The Las1L endoribonuclease (human) requires its binding partner Grc3 (NOL9 ortholog in yeast) for specific C2 cleavage of pre-rRNA both in vitro and in vivo. Grc3 and Las1 assemble into a tetrameric complex; Las1 reciprocally activates Grc3 kinase activity exclusively toward single-stranded RNA substrates. This cross-activation establishes Grc3/Las1 as a unique member of the RNaseL/Ire1 RNA splicing family.\",\n      \"method\": \"In vitro reconstitution of endoribonuclease cleavage assay, in vitro polynucleotide kinase assay, site-directed mutagenesis, in vivo pre-rRNA processing assays in S. cerevisiae, native mass spectrometry for complex stoichiometry\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with mutagenesis, validated in vivo, multiple orthogonal methods; strong mechanistic resolution\",\n      \"pmids\": [\"28652339\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Grc3 (NOL9 ortholog) has distinct substrate preference for RNA over DNA substrates in vitro. Disruption of conserved residues at the Grc3 kinase active site abolishes Grc3-directed Las1-mediated pre-rRNA cleavage both in vitro and in vivo, establishing that Grc3 kinase activity is directly coupled to Las1 endonuclease activity during pre-rRNA processing.\",\n      \"method\": \"In vitro polynucleotide kinase assay with RNA/DNA substrates, active-site mutagenesis, in vitro cleavage assay, in vivo pre-rRNA processing assays in S. cerevisiae\",\n      \"journal\": \"RNA (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — enzymatic reconstitution with active-site mutagenesis validated in vivo\",\n      \"pmids\": [\"29440475\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Human NOL9 forms a higher-order complex with Las1L to constitute the ITS2 pre-rRNA endonuclease-kinase machinery. NOL9 contains a nucleolar localization sequence (NoLS) that is responsible for nucleolar transport of the assembled Las1L–NOL9 complex. Structural analysis by high-resolution imaging defines the spatial organization of Las1L–NOL9 within nucleolar sub-structures linked to late pre-rRNA processing. Specific regions of both proteins orchestrate the intricate higher-order architecture of the complex.\",\n      \"method\": \"Co-immunoprecipitation, deletion mapping, confocal and super-resolution fluorescence microscopy (nucleolar sub-structure imaging), subcellular fractionation, domain mutagenesis\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP with deletion analysis, direct localization with functional NoLS mapping, multiple orthogonal methods\",\n      \"pmids\": [\"31288032\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"In zebrafish, loss-of-function mutation of nol9 causes defective 28S rRNA processing, hypoplastic pancreas, liver, and intestine, and reduced hematopoietic stem/progenitor cells, definitive erythrocytes, and lymphocytes due to impaired proliferation of progenitor cells. The hematopoietic (but not pancreatic) defects are rescued by genetic loss of Tp53, indicating that the hematopoietic phenotype is p53-dependent. mTOR pathway activation by L-Leucine does not rescue either defect.\",\n      \"method\": \"Forward genetic screen, loss-of-function zebrafish mutant, Northern blotting for rRNA, genetic epistasis with tp53 mutant, L-Leucine mTOR activation, flow cytometry, ultrastructural analysis\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean loss-of-function in vertebrate model with defined molecular (rRNA processing) and cellular phenotypes, genetic epistasis establishing p53-dependent pathway\",\n      \"pmids\": [\"26624285\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"The LAS1–NOL9 protein–protein interaction is required for 28S rRNA maturation; covalent inhibition of LAS1 at C264 by the compound HEN-463 disrupts LAS1–NOL9 interaction, causes cytoplasmic translocation of LAS1, inhibits 28S rRNA maturation, activates the NPM1–MDM2–p53 pathway leading to p53 stabilization, and selectively kills NPM1-mutant AML cells.\",\n      \"method\": \"Covalent small-molecule targeting, co-immunoprecipitation (LAS1–NOL9 interaction), subcellular fractionation/immunofluorescence (LAS1 translocation), Northern/qRT-PCR (rRNA processing), Western blotting (p53 pathway), cell viability and apoptosis assays\",\n      \"journal\": \"Pharmacological research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — Co-IP disruption with functional rRNA and pathway readouts; single lab, pharmacological rather than genetic dissection of NOL9 function per se\",\n      \"pmids\": [\"36796466\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"NOL9 expression in hepatocellular carcinoma (HCC) is regulated by DNA methylation at specific CpG sites (involving DNMT1) and by the transcription factor ZNF384. NOL9 knockdown inhibits HCC cell proliferation and promotes apoptosis in vitro and reduces tumor growth in vivo; overexpression has the opposite effect. Mechanistically, NOL9-mediated cell proliferation in HCC is dependent on activation of the Wnt/β-catenin signaling pathway.\",\n      \"method\": \"siRNA knockdown and overexpression in HCC cell lines, in vivo xenograft tumor growth assay, bisulfite sequencing/methylation analysis, luciferase reporter and Western blotting for Wnt/β-catenin pathway, flow cytometry (apoptosis/cell cycle)\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — loss- and gain-of-function with in vivo validation and pathway reporter; single lab, Wnt/β-catenin link is mechanistic but upstream connection to NOL9's known kinase activity is not established\",\n      \"pmids\": [\"39955289\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NOL9 is a nucleolar polynucleotide 5'-kinase that associates with pre-60S ribosomal particles and, together with the endoribonuclease Las1L, forms a higher-order tetrameric ITS2 endonuclease-kinase complex in which NOL9's kinase activity phosphorylates pre-rRNA cleavage products and Las1L reciprocally activates NOL9 kinase activity toward single-stranded RNA; this coupled cleavage-phosphorylation is required for processing of the 32S precursor into mature 5.8S and 28S rRNAs, and NOL9 encodes a nucleolar localization sequence that directs the assembled Las1L–NOL9 complex to the nucleolus for late pre-rRNA processing events.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"NOL9 is a nucleolar polynucleotide 5'-kinase essential for the maturation of 5.8S and 28S ribosomal RNAs and 60S ribosomal subunit biogenesis. It associates with pre-60S ribosomal particles and phosphorylates the 5' ends of ITS2 cleavage products, thereby licensing their exonucleolytic degradation; depletion causes a specific block in 32S pre-rRNA processing [PMID:21063389]. NOL9 forms a higher-order endonuclease–kinase complex with the Las1L endoribonuclease, and its nucleolar localization sequence directs nuclear import of the assembled complex to the site of late pre-rRNA processing [PMID:31288032, PMID:36796466]. Loss of Nol9 function in zebrafish impairs 28S rRNA processing and triggers a p53-dependent checkpoint that restricts hematopoietic stem/progenitor cell proliferation [PMID:26624285].\",\n  \"teleology\": [\n    {\n      \"year\": 2010,\n      \"claim\": \"Establishing that NOL9 is a polynucleotide 5'-kinase on pre-60S particles whose activity is required for 32S→5.8S/28S rRNA maturation resolved a missing enzymatic step in human ITS2 processing.\",\n      \"evidence\": \"In vitro kinase assay, sucrose-gradient sedimentation of HeLa nuclear extracts, siRNA knockdown with Northern blot rRNA analysis\",\n      \"pmids\": [\"21063389\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Endoribonuclease partner for ITS2 cleavage not yet identified\",\n        \"Structural basis of substrate recognition unknown\",\n        \"Whether the kinase activity is catalytically sufficient or requires cofactors not tested\"\n      ]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Demonstrating that Nol9 loss-of-function in zebrafish activates a p53-dependent checkpoint that restricts hematopoietic progenitor proliferation established the physiological consequence of impaired ribosome biogenesis through this pathway in a vertebrate model.\",\n      \"evidence\": \"Zebrafish nol9 loss-of-function mutant, genetic epistasis with tp53, rRNA processing and progenitor cell analysis\",\n      \"pmids\": [\"26624285\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Mechanism connecting ribosome biogenesis failure to p53 stabilization not delineated\",\n        \"Pancreatic progenitor defect is p53-independent — alternative pathway unknown\",\n        \"Whether kinase-dead Nol9 phenocopies null not tested\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identification of the Las1L–NOL9 endonuclease–kinase complex and the NOL9 nucleolar localization sequence explained how ITS2 cleavage and 5'-phosphorylation are spatially coupled within the nucleolus.\",\n      \"evidence\": \"Reciprocal co-immunoprecipitation, electron microscopy, domain-deletion mapping with localization rescue in human cells\",\n      \"pmids\": [\"31288032\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Stoichiometry and full subunit composition of the complex not resolved\",\n        \"Atomic-resolution structure of the Las1L–NOL9 interface unavailable\",\n        \"Whether NOL9 has additional roles independent of Las1L not addressed\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Chemical-genetic disruption of the LAS1–NOL9 interaction by covalent inhibition of LAS1 C264 showed that complex integrity is required for 28S rRNA processing and that its disruption stabilizes p53 via the NPM1–MDM2 axis, linking the complex to a targetable vulnerability in NPM1-mutant AML.\",\n      \"evidence\": \"Covalent inhibitor HEN-463 targeting LAS1, co-IP of LAS1-NOL9, rRNA processing and p53 pathway analysis in AML cells\",\n      \"pmids\": [\"36796466\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single inhibitor study — off-target effects not fully excluded\",\n        \"Whether NOL9 kinase activity per se is affected by LAS1 C264 modification not directly measured\",\n        \"Selectivity for NPM1-mutant versus wild-type contexts not deeply explored\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"An atomic-resolution structure of the Las1L–NOL9 complex, identification of all in vivo RNA substrates, and the mechanism by which ribosome biogenesis stress is transduced to p53 remain to be established.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No high-resolution structure of the human Las1L–NOL9 complex\",\n        \"Full repertoire of in vivo phosphorylated RNA substrates not mapped\",\n        \"Direct versus indirect mechanism linking NOL9 loss to p53 stabilization unresolved\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005730\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [0, 1, 2, 4]},\n      {\"term_id\": \"R-HSA-1852241\", \"supporting_discovery_ids\": [0, 2]}\n    ],\n    \"complexes\": [\n      \"Las1L–NOL9 ITS2 endonuclease–kinase complex\"\n    ],\n    \"partners\": [\n      \"LAS1L\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"NOL9 is a nucleolar polynucleotide 5'-hydroxyl-kinase essential for ribosome biogenesis, specifically the processing of the 32S precursor into mature 5.8S and 28S rRNAs. NOL9 forms a tetrameric complex with the endoribonuclease Las1L in which Las1L reciprocally activates NOL9 kinase activity toward single-stranded RNA, coupling ITS2 endonucleolytic cleavage to 5'-phosphorylation of cleavage products required for subsequent exonucleolytic trimming [PMID:28652339, PMID:29440475]. NOL9 encodes a nucleolar localization sequence that directs the assembled Las1L–NOL9 complex to the nucleolus for late pre-rRNA processing [PMID:31288032]. Loss of NOL9 function in zebrafish causes defective 28S rRNA processing, p53-dependent hematopoietic failure, and visceral organ hypoplasia, and disruption of the LAS1–NOL9 interaction pharmacologically activates the NPM1–MDM2–p53 surveillance pathway [PMID:26624285, PMID:36796466].\",\n  \"teleology\": [\n    {\n      \"year\": 2010,\n      \"claim\": \"Establishing NOL9/Grc3 as an RNA 5'-kinase linked to ribosome biogenesis resolved the enzymatic identity of the gene and showed its kinase activity is required for 32S pre-rRNA processing to generate 5.8S and 28S rRNAs.\",\n      \"evidence\": \"siRNA knockdown in HeLa cells, in vitro polynucleotide kinase assay, sucrose gradient sedimentation, Northern blotting (human); genetic depletion, ChIP, Pol I transcription run-on (yeast)\",\n      \"pmids\": [\"21063389\", \"20814424\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Identity of the direct RNA substrates phosphorylated by NOL9 in vivo was not determined\",\n        \"How NOL9 kinase activity feeds into exonucleolytic trimming remained unclear\",\n        \"Whether NOL9 acts alone or requires a partner was unknown\"\n      ]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identification of Las1 as the major Grc3/NOL9-interacting protein demonstrated that the kinase functions within a dedicated endonuclease–kinase module on pre-60S particles, explaining the epistatic overlap of their depletion phenotypes.\",\n      \"evidence\": \"Reciprocal co-immunoprecipitation, genetic depletion, AP-MS, Northern blotting in S. cerevisiae and S. pombe\",\n      \"pmids\": [\"23175604\", \"21385875\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Stoichiometry and architecture of the Las1–Grc3 complex were unresolved\",\n        \"Whether Las1 endonuclease activity depends on Grc3 was not tested biochemically\",\n        \"The Grc3 role in heterochromatic silencing reported in S. pombe was not confirmed in other organisms\"\n      ]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"A vertebrate loss-of-function model in zebrafish established that nol9 is essential for organismal development, linking defective 28S rRNA processing to p53-dependent hematopoietic failure and p53-independent visceral organ hypoplasia.\",\n      \"evidence\": \"Forward genetic screen, nol9 mutant zebrafish, Northern blot for rRNA, genetic epistasis with tp53\",\n      \"pmids\": [\"26624285\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether the p53-independent pancreatic phenotype reflects a ribosome-independent NOL9 function was unclear\",\n        \"Mammalian in vivo consequences of NOL9 loss were not examined\"\n      ]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Biochemical reconstitution revealed that Las1 and Grc3 cross-activate each other — Las1 stimulates Grc3 kinase activity toward ssRNA and Grc3 is required for Las1 C2 endonuclease cleavage — establishing a coupled cleavage-phosphorylation mechanism for ITS2 processing.\",\n      \"evidence\": \"In vitro reconstitution of endonuclease and kinase assays, active-site mutagenesis validated in vivo, native mass spectrometry for tetrameric stoichiometry in S. cerevisiae\",\n      \"pmids\": [\"28652339\", \"29440475\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis for reciprocal activation was not determined\",\n        \"Whether the human Las1L–NOL9 complex has identical stoichiometry and cross-activation was not directly shown\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Mapping the human Las1L–NOL9 complex architecture showed that NOL9 carries a nucleolar localization sequence responsible for directing the assembled complex to the nucleolus, explaining how the ITS2 processing machinery reaches its substrate.\",\n      \"evidence\": \"Deletion mapping, co-immunoprecipitation, confocal and super-resolution microscopy of nucleolar sub-structures in human cells\",\n      \"pmids\": [\"31288032\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"High-resolution atomic structure of the human Las1L–NOL9 complex is still lacking\",\n        \"Whether additional factors regulate nucleolar import or retention of the complex is unknown\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Pharmacological disruption of the LAS1–NOL9 interaction by a covalent LAS1 inhibitor confirmed the interaction is functionally essential for 28S rRNA maturation and demonstrated that its loss activates the NPM1–MDM2–p53 nucleolar stress pathway, with therapeutic selectivity in NPM1-mutant AML.\",\n      \"evidence\": \"Covalent small-molecule targeting of LAS1 C264, co-immunoprecipitation, Northern blot, subcellular fractionation, cell viability assays in AML lines\",\n      \"pmids\": [\"36796466\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Pharmacological specificity of HEN-463 beyond LAS1 was not exhaustively profiled\",\n        \"Whether NOL9 protein stability or activity is directly affected by the compound is unclear\",\n        \"In vivo efficacy in AML models was not reported\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"NOL9 was linked to hepatocellular carcinoma cell proliferation via Wnt/β-catenin signaling, expanding its functional repertoire beyond ribosome biogenesis, though the mechanistic bridge between NOL9's kinase activity and Wnt pathway activation is undefined.\",\n      \"evidence\": \"siRNA knockdown and overexpression in HCC cell lines, in vivo xenograft, bisulfite sequencing, luciferase reporter for Wnt pathway\",\n      \"pmids\": [\"39955289\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No mechanistic connection between NOL9 polynucleotide kinase activity and Wnt/β-catenin signaling was established\",\n        \"Whether the proliferative effect is secondary to ribosome biogenesis defects and p53 activation was not tested\",\n        \"Single-lab finding without independent replication\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"An atomic-resolution structure of the human Las1L–NOL9 complex and identification of the in vivo RNA substrates phosphorylated by NOL9 remain key open questions for understanding how coupled cleavage-phosphorylation is orchestrated during ITS2 processing.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No high-resolution structure of the human Las1L–NOL9 complex exists\",\n        \"The precise in vivo RNA substrates of NOL9 kinase have not been mapped by crosslinking or related approaches\",\n        \"Whether NOL9 has physiologically relevant functions outside ribosome biogenesis remains unresolved\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 1, 4, 5]},\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [0, 4, 5]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005730\", \"supporting_discovery_ids\": [0, 6]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [3, 6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0005654\", \"supporting_discovery_ids\": []},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [0, 4, 5, 7]},\n      {\"term_id\": \"R-HSA-1852241\", \"supporting_discovery_ids\": [0, 7]}\n    ],\n    \"complexes\": [\n      \"Las1L–NOL9 ITS2 endonuclease-kinase complex\",\n      \"pre-60S ribosomal particle\"\n    ],\n    \"partners\": [\n      \"LAS1L\",\n      \"RIX1\",\n      \"IPI1\",\n      \"NSA1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\nWait — I notice I accidentally included a GO cellular component term (GO:0005654) in the pathway array. Let me correct that.\n\n```json\n{\n  \"mechanistic_narrative\": \"NOL9 is a nucleolar polynucleotide 5'-hydroxyl-kinase essential for ribosome biogenesis, specifically the processing of the 32S precursor into mature 5.8S and 28S rRNAs. NOL9 forms a tetrameric complex with the endoribonuclease Las1L in which Las1L reciprocally activates NOL9 kinase activity toward single-stranded RNA, coupling ITS2 endonucleolytic cleavage to 5'-phosphorylation of cleavage products required for subsequent exonucleolytic trimming [PMID:28652339, PMID:29440475]. NOL9 encodes a nucleolar localization sequence that directs the assembled Las1L–NOL9 complex to the nucleolus for late pre-rRNA processing [PMID:31288032]. Loss of NOL9 function in zebrafish causes defective 28S rRNA processing, p53-dependent hematopoietic failure, and visceral organ hypoplasia, and disruption of the LAS1–NOL9 interaction pharmacologically activates the NPM1–MDM2–p53 surveillance pathway [PMID:26624285, PMID:36796466].\",\n  \"teleology\": [\n    {\n      \"year\": 2010,\n      \"claim\": \"Establishing NOL9/Grc3 as an RNA 5'-kinase linked to ribosome biogenesis resolved the enzymatic identity of the gene and showed its kinase activity is required for 32S pre-rRNA processing to generate 5.8S and 28S rRNAs.\",\n      \"evidence\": \"siRNA knockdown in HeLa cells, in vitro polynucleotide kinase assay, sucrose gradient sedimentation, Northern blotting (human); genetic depletion, ChIP, Pol I transcription run-on (yeast)\",\n      \"pmids\": [\"21063389\", \"20814424\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Identity of the direct RNA substrates phosphorylated by NOL9 in vivo was not determined\",\n        \"How NOL9 kinase activity feeds into exonucleolytic trimming remained unclear\",\n        \"Whether NOL9 acts alone or requires a partner was unknown\"\n      ]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identification of Las1 as the major Grc3/NOL9-interacting protein demonstrated that the kinase functions within a dedicated endonuclease–kinase module on pre-60S particles, explaining the epistatic overlap of their depletion phenotypes.\",\n      \"evidence\": \"Reciprocal co-immunoprecipitation, genetic depletion, AP-MS, Northern blotting in S. cerevisiae and S. pombe\",\n      \"pmids\": [\"23175604\", \"21385875\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Stoichiometry and architecture of the Las1–Grc3 complex were unresolved\",\n        \"Whether Las1 endonuclease activity depends on Grc3 was not tested biochemically\",\n        \"The Grc3 role in heterochromatic silencing reported in S. pombe was not confirmed in other organisms\"\n      ]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"A vertebrate loss-of-function model in zebrafish established that nol9 is essential for organismal development, linking defective 28S rRNA processing to p53-dependent hematopoietic failure and p53-independent visceral organ hypoplasia.\",\n      \"evidence\": \"Forward genetic screen, nol9 mutant zebrafish, Northern blot for rRNA, genetic epistasis with tp53\",\n      \"pmids\": [\"26624285\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether the p53-independent pancreatic phenotype reflects a ribosome-independent NOL9 function was unclear\",\n        \"Mammalian in vivo consequences of NOL9 loss were not examined\"\n      ]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Biochemical reconstitution revealed that Las1 and Grc3 cross-activate each other — Las1 stimulates Grc3 kinase activity toward ssRNA and Grc3 is required for Las1 C2 endonuclease cleavage — establishing a coupled cleavage-phosphorylation mechanism for ITS2 processing.\",\n      \"evidence\": \"In vitro reconstitution of endonuclease and kinase assays, active-site mutagenesis validated in vivo, native mass spectrometry for tetrameric stoichiometry in S. cerevisiae\",\n      \"pmids\": [\"28652339\", \"29440475\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis for reciprocal activation was not determined\",\n        \"Whether the human Las1L–NOL9 complex has identical stoichiometry and cross-activation was not directly shown\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Mapping the human Las1L–NOL9 complex architecture showed that NOL9 carries a nucleolar localization sequence responsible for directing the assembled complex to the nucleolus, explaining how the ITS2 processing machinery reaches its substrate.\",\n      \"evidence\": \"Deletion mapping, co-immunoprecipitation, confocal and super-resolution microscopy of nucleolar sub-structures in human cells\",\n      \"pmids\": [\"31288032\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"High-resolution atomic structure of the human Las1L–NOL9 complex is still lacking\",\n        \"Whether additional factors regulate nucleolar import or retention of the complex is unknown\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Pharmacological disruption of the LAS1–NOL9 interaction by a covalent LAS1 inhibitor confirmed the interaction is functionally essential for 28S rRNA maturation and demonstrated that its loss activates the NPM1–MDM2–p53 nucleolar stress pathway, with therapeutic selectivity in NPM1-mutant AML.\",\n      \"evidence\": \"Covalent small-molecule targeting of LAS1 C264, co-immunoprecipitation, Northern blot, subcellular fractionation, cell viability assays in AML lines\",\n      \"pmids\": [\"36796466\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Pharmacological specificity of HEN-463 beyond LAS1 was not exhaustively profiled\",\n        \"Whether NOL9 protein stability or activity is directly affected by the compound is unclear\",\n        \"In vivo efficacy in AML models was not reported\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"NOL9 was linked to hepatocellular carcinoma cell proliferation via Wnt/β-catenin signaling, expanding its functional repertoire beyond ribosome biogenesis, though the mechanistic bridge between NOL9's kinase activity and Wnt pathway activation is undefined.\",\n      \"evidence\": \"siRNA knockdown and overexpression in HCC cell lines, in vivo xenograft, bisulfite sequencing, luciferase reporter for Wnt pathway\",\n      \"pmids\": [\"39955289\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No mechanistic connection between NOL9 polynucleotide kinase activity and Wnt/β-catenin signaling was established\",\n        \"Whether the proliferative effect is secondary to ribosome biogenesis defects and p53 activation was not tested\",\n        \"Single-lab finding without independent replication\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"An atomic-resolution structure of the human Las1L–NOL9 complex and identification of the in vivo RNA substrates phosphorylated by NOL9 remain key open questions for understanding how coupled cleavage-phosphorylation is orchestrated during ITS2 processing.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No high-resolution structure of the human Las1L–NOL9 complex exists\",\n        \"The precise in vivo RNA substrates of NOL9 kinase have not been mapped by crosslinking or related approaches\",\n        \"Whether NOL9 has physiologically relevant functions outside ribosome biogenesis remains unresolved\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 1, 4, 5]},\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [0, 4, 5]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005730\", \"supporting_discovery_ids\": [0, 6]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [3, 6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [0, 4, 5, 7]},\n      {\"term_id\": \"R-HSA-1852241\", \"supporting_discovery_ids\": [0, 7]}\n    ],\n    \"complexes\": [\n      \"Las1L–NOL9 ITS2 endonuclease-kinase complex\",\n      \"pre-60S ribosomal particle\"\n    ],\n    \"partners\": [\n      \"LAS1L\",\n      \"RIX1\",\n      \"IPI1\",\n      \"NSA1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}